Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma
Clinical trial NCT07546630 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07546630
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2028-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.